Shirihai Orian: Difference between revisions
From Bioblast
m (Gnaiger Erich moved page Shirihai O to Shirihai Orian over redirect) |
No edit summary Β |
||
(10 intermediate revisions by 3 users not shown) | |||
Line 3: | Line 3: | ||
|lastname=Shirihai | |lastname=Shirihai | ||
|firstname=Orian | |firstname=Orian | ||
|title= | |title=MD, PhD, Professor, Molecular and Medical Pharmacology | ||
|institution=[[File:Shirihai_O.jpg|right|150px]]Dept. Molecular and Medical Pharmacology | |||
33-131E Center for Health Sciences | |||
Β | |||
University of California, Los Angeles, UCLA | |||
|address= | |address=10833 Le Conte Ave | ||
|area code= | |area code=90095 | ||
|city= | |city=Los Angeles | ||
|state= | |state=California (CA) | ||
|country=USA | |country=USA | ||
|mailaddress= | |mailaddress=OShirihai@mednet.ucla.edu | ||
|weblink=https://profiles.ucla.edu/orian.shirihai | |||
}} | }} | ||
== Participated at == | |||
::::* [[MiP2023 Obergurgl AT]] | |||
::::* [[MiPNet28.03 IOC157 Los Angeles US |2023 O2k-Workshop UCLA]] | |||
::::* [[MiP2014| MiP2014 Obergurgl AT]] | |||
= | {{Labelingperson | ||
|field of research=Basic, Pharmacological | |||
}} |
Latest revision as of 11:15, 14 December 2023
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Shirihai Orian
Name | Shirihai Orian, MD, PhD, Professor, Molecular and Medical Pharmacology |
---|---|
Institution | Dept. Molecular and Medical Pharmacology
33-131E Center for Health Sciences University of California, Los Angeles, UCLA |
Address | 10833 Le Conte Ave, 90095 |
City | Los Angeles |
State/Province | California (CA) |
Country | USA |
[email protected] | |
Weblink | https://profiles.ucla.edu/orian.shirihai |
O2k-Network Lab | US CA Los Angeles Shirihai O |
Participated at
Labels:
Field of research: Basic, Pharmacological
Publications
Published | Reference | |
---|---|---|
Rodriguez-Nuevo 2018 EMBO J | 2018 | RodrΓguez-Nuevo A, DΓaz-Ramos A, Noguera E, DΓaz-SΓ‘ez F, Duran X, MuΓ±oz JP, Romero M, Plana N, SebastiΓ‘n D, Tezze C, Romanello V, Ribas F, Seco J, Planet E, Doctrow SR, GonzΓ‘lez J, BorrΓ s M, Liesa M, PalacΓn M, Vendrell J, Villarroya F, Sandri M, Shirihai O, Zorzano A (2018) Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency. EMBO J 37. |
Abstracts
Published | Reference | |
---|---|---|
Shirihai 2023 MiP2023 | 2023 | Inhibition of ATP synthase hydrolytic activity restores cellular energy homeostasis in conditions of impaired respiration. |
Cerqueira 2016 Abstract Mito Xmas Meeting Innsbruck | 2016 | The Deubiquitinating (DUB) protein Ubiquitin carboxyl- terminal hydrolase L1 (UCH-L1) regulates Mitofusin-2 levels and mitochondrial function in mammalian cell lines and in D. Melanogaster. |
Shirihai 2014 Abstract MiP2014 | 2014 | Mitochondrial dynamics and quality control, a conflict of interest. |
Trudeau 2014 Abstract MiP2014 | 2014 | Role of mitochondrial fusion and motility in distributing young mitochondrial protein and removing old protein from the mitochondrial network. |